Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study to Identify the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

NCT03412058 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03412058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03412058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study to Identify the Predictive Factors of Response to PD-1 or PD-L1 Antagonists
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Terminated
Start date
June 27, 2018
Completion date
December 1, 2025
Enrollment
152 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, melanoma, non small cell lung cancer